BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  AbbVie is Enabling Students Diagnosed with Immunological Diseases to Shine

  The AbbVie Immunology Scholarship provides financial support to students living with chronic, immune-mediated diseases who are pursuing higher education in the United States.

  June 1, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  Passage Bio CEO Bruce Goldsmith Abruptly Steps Down

  Although Bruce Goldsmith will no longer serve on the executive team, he will remain with Passage Bio for a short period as a strategic advisor to the interim CEO.

  June 1, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Career Advice

  Logistical skills: The Panacea The Pharma Sector Needs

  With a swirl of rumors around the changes in ownership in the pharma industry, this invariably triggers reviews of business strategies. Because of this, wider skillsets from related sectors are needed.

  June 1, 2022

   · 

  4 min read

   · 

  Leigh Anderson
• 

  Drug Development

  Sage/Biogen Depression Drug Yields Positive Results in Postpartum Depression

  Sage Therapeutics and partner Biogen shared news that their phase III Skylark study has yielded promising results for women suffering from severe postpartum depression (PPD).

  June 1, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Drug Development

  BMS Preps Lupus Treatment to Become Third Approval in Space

  Bristol Myers Squibb (BMS) has announced late-breaking data showing deucravacitinib significant efficacy at the primary endpoint for the treatment of systemic lupus erythematosus (SLE).

  June 1, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Report Predicts AbbVie Could Become Top-Selling Pharma Company by 2028

  The report suggests that AbbVie’s sales will be approximately $65.7 billion within the next six years, with Roche right behind at $65 billion.

  June 1, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Axsome’s Phase III Results Show Significant Improvement in Depression

  Axsome Therapeutics published results of its Phase III trial of AXS-05 that demonstrated rapid, substantial and statistically significant improvement in depressive symptoms.

  June 1, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Pfizer to Sell Stake in Haleon Following GSK De-Merger

  Pfizer intends to sell off its stake when the de-merger occurs and seek the most profitable sale of its share of Haleon to maximize value for company stockholders.

  June 1, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Sanofi, Sobi and Midatech Gain FDA’s Vote of Confidence in Hemophilia, Cancer

  The FDA has issued special designations that could improve the lives of millions with recurrent glioblastoma or hemophilia diagnoses.

  June 1, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano M.S.
• 

  Novel Herpesvirus Research, Vaccines Breaking Ground

  There are more than 100 known herpesviruses, eight of which infect only humans. Here’s a look at recent stories and research on herpesviruses.

  June 1, 2022

   · 

  5 min read

   · 

  Mark Terry